Literature DB >> 16378604

A comparison of three techniques for quantitative carbohydrate analysis used in characterization of therapeutic antibodies.

Joseph Siemiatkoski1, Yelena Lyubarskaya, Damian Houde, Samnang Tep, Rohin Mhatre.   

Abstract

A comparison of three techniques for quantitative analysis of galactosylation present on immunoglobulins is described. ESIMS, MALDI-TOF MS, and anion-exchange chromatography with fluorescence detection were evaluated in terms of repeatability, limit of quantitation, selectivity, and linearity. A recombinant monoclonal IgG was enzymatically modified in vitro to produce essentially completely galactosylated and degalactosylated forms of the immunoglobulin. Samples of known galactosylation levels were prepared by mixing the modified forms with the native form of the immunoglobulin. Good repeatability and linearity were demonstrated for all three assays (RSDs<1.0%, correlation coefficients>0.99). Differences in selectivity, sensitivity, and other performance aspects of the three techniques are also discussed in this paper.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378604     DOI: 10.1016/j.carres.2005.11.024

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  8 in total

1.  Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab.

Authors:  Carola W N Damen; Weibin Chen; Asish B Chakraborty; Mike van Oosterhout; Jeffrey R Mazzeo; John C Gebler; Jan H M Schellens; Hilde Rosing; Jos H Beijnen
Journal:  J Am Soc Mass Spectrom       Date:  2009-08-07       Impact factor: 3.109

2.  Analysis of reduced monoclonal antibodies using size exclusion chromatography coupled with mass spectrometry.

Authors:  Hongcheng Liu; Georgeen Gaza-Bulseco; Chris Chumsae
Journal:  J Am Soc Mass Spectrom       Date:  2009-08-28       Impact factor: 3.109

Review 3.  In vitro and in vivo modifications of recombinant and human IgG antibodies.

Authors:  Hongcheng Liu; Gomathinayagam Ponniah; Hui-Min Zhang; Christine Nowak; Alyssa Neill; Nidia Gonzalez-Lopez; Rekha Patel; Guilong Cheng; Adriana Z Kita; Bruce Andrien
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

4.  Structural and functional characterization of the trifunctional antibody catumaxomab.

Authors:  Dirk Chelius; Peter Ruf; Patrick Gruber; Matthias Plöscher; Reinhard Liedtke; Eva Gansberger; Juergen Hess; Michael Wasiliu; Horst Lindhofer
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

5.  Glycan analysis by isobaric aldehyde reactive tags and mass spectrometry.

Authors:  Shuang Yang; Wei Yuan; Weiming Yang; Jianying Zhou; Robert Harlan; James Edwards; Shuwei Li; Hui Zhang
Journal:  Anal Chem       Date:  2013-08-12       Impact factor: 6.986

Review 6.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

7.  Endosperm-specific expression of human acid beta-glucosidase in a waxy rice.

Authors:  Tamara Patti; Bruno Bembi; Piero Cristin; Flavia Mazzarol; Erika Secco; Carla Pappalardo; Rita Musetti; Maurizio Martinuzzi; Serena Versolatto; Roberta Cariati; Andrea Dardis; Stefano Marchetti
Journal:  Rice (N Y)       Date:  2012-12-06       Impact factor: 4.783

Review 8.  Proteoforms and their expanding role in laboratory medicine.

Authors:  Lauren M Forgrave; Meng Wang; David Yang; Mari L DeMarco
Journal:  Pract Lab Med       Date:  2021-11-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.